APPENDIX TABLE 1.
Post-hoc Analyses.*
| Change in Body Weight (kg) | Change in Fat Mass (kg) | |||||
|---|---|---|---|---|---|---|
| Sample evaluated (n) | Calcium | Placebo | P Value | Calcium | Placebo | P Value |
| Model including group by race and group by sex interactions | ||||||
| All subjects (335) | +0.42 (−1.10 to +1.95) | −0.54 (−2.44 to +1.36) | .64 | +0.39 (−0.64 to +1.41) | −0.33 (−1.60 to +0.93) | .38 |
| Non-Hispanic black (101) | +0.73 (−1.99 to +3.44) | −0.12 (−2.41 to +2.22) | .53 | +0.22 (−2.15 to +2.58) | −0.27 (−1.97 to +1.43) | .53 |
| Women (244) | +0.55 (−1.12 to +2.22) | −0.37 (−2.46 to +1.73) | .94 | +0.51 (−0.60 to +1.63) | −0.07 (−1.46 to +1.33) | .78 |
| Subgroup Analyses: | ||||||
| Calcium intake <600 mg/d (80) | −0.79 (−3.87 to +2.27) | −0.64 (−3.94 to +2.65) | .89 | −0.10 (−2.42 to +2.21 | −0.40 (−2.87 to +2.07) | .75 |
| Calcium intake < 1200 mg/d (251) | +0.15 (−0.37 to +0.66) | −0.05 (−0.57 to +0.48) | .45 | −0.07 (−1.00 to +0.61) | +0.17 (−0.76 to +1.12) | .60 |
| Obesity, BMI ≥ 30 kg/m2 (203) | +0.13 (−1.86 to +2.11) | +0.46 (−1.62 to +2.53) | .72 | +0.11 (−1.23 to +1.46) | +0.35 (−1.05 to +1.75) | .71 |
| ≥ 90% adherent (152) | −1.21 (−3.39 to +0.97) | −1.16 (−3.74 to +1.15) | .96 | −0.68 (−2.10 to +1.75) | −0.55 (−2.06 to +0.96) | .86 |
| Did not participate in a commercial weight loss program (304) | +0.22 (−1.42 to +1.86) | +0.02 (−1.60 to +1.65) | .75 | +0.33 (−0.82 to +1.47) | +0.36 (−0.77 to +1.49) | .94 |
*
Estimated marginal means (95th percentile confidence intervals).